Sinil Pharm Co., Ltd. (012790) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sinil Pharm Co., Ltd. (012790:KRX), powered by AI.

Current Price
₩5,410
P/E Ratio
8.6
Market Cap
64.8B
Sector
Healthcare
What is the Sinil Pharm Co., Ltd. stock price forecast?

Sinil Pharm Co., Ltd. is currently trading at ₩5,410. View real-time AI analysis on Alpha Lenz.

What is Sinil Pharm Co., Ltd. insider trading activity?

View the latest insider trading data for Sinil Pharm Co., Ltd. on Alpha Lenz.

What is Sinil Pharm Co., Ltd.'s P/E ratio?

Sinil Pharm Co., Ltd.'s P/E ratio is 8.6.

Sinil Pharm Co., Ltd.

KRX · 012790
₩5,410+20(+0.37%)Market closedKRX regular session 09:00–15:30 KST
Ask about Sinil Pharm Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sinil Pharm Co., Ltd. trades at a P/E of 8.6 (undervalued) with modest ROE of 5.0%.

Ask for details

Company Overview

Sinil Pharm Co., Ltd. is a pharmaceutical company dedicated to the development, manufacture, and distribution of a diverse range of pharmaceutical products. Sinil Pharm focuses on producing both prescription medications and over-the-counter drugs, addressing various therapeutic areas and contributing to public health. Key areas of production include analgesics, antibiotics, and lifestyle-related medications, providing essential healthcare solutions to a broad spectrum of customers. As an integral player in the pharmaceutical industry, Sinil Pharm Co., Ltd. supplies its products to hospitals, clinics, and pharmacies, ensuring accessibility to quality medical solutions. The company's role in the market is pivotal as it supports healthcare systems by offering reliable and affordable pharmaceuticals. Sinil Pharm Co., Ltd.'s continued commitment to innovation and adherence to regulatory standards underscores its importance in the global pharmaceutical landscape.

CEO홍재현
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩64,846,505,150Market Cap
₩80,563,639,510Revenue
11.99MShares Out
0Employees

Margins

41.50%Gross
18.03%EBITDA
9.17%Operating
10.67%Pre-Tax
9.35%Net

Valuation

8.61P/E
0.43P/B
0.80EV/Sales
3.84EV/EBITDA
9.09P/FCF

Growth (CAGR)

0.23%Rev 3Yr
5.57%Rev 5Yr
-18.53%Op Inc 3Yr
1.60%Op Inc 5Yr
-14.75%Net Inc 3Yr
-0.04%Net Inc 5Yr

Returns

4.49%ROA
5.04%ROE
5.14%ROIC

Financial Health

₩9,313,349,080Cash & Cash Equivalents
₩7,825,934,280Net Debt
11.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sinil Pharm Co., Ltd. (ticker: 012790) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $64.8B.

The current price is ₩5,410 with a P/E ratio of 8.61x and P/B of 0.43x.

ROE is 5.04% and operating margin is 9.17%. Annual revenue is $80.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sinil Pharm Co., Ltd. (012790) Stock Forecast 2026 ₩5,410 — Price, Financials & Analyst Targets | Alpha Lenz